Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
7.33
-0.26 (-3.43%)
At close: Aug 15, 2025, 1:10 PM

Passage Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
3.08M 3.72M 3.68M 1.54M
Gross Profit
-3.08M -3.72M -3.68M -1.54M
Operating Income
-70.4M -100.14M -138.39M -185.73M
Interest Income
4.3M 5.6M 2.27M 343K
Pretax Income
-64.77M -102.06M -136.13M -185.39M
Net Income
-64.77M -102.06M -136.13M -185.39M
Selling & General & Admin
24.99M 41.58M 49.34M 60.06M
Research & Development
40.18M 59.56M 86.05M 117.67M
Other Expenses
n/a -4.72M n/a -1.54M
Operating Expenses
65.17M 96.42M 135.39M 176.19M
Interest Expense
n/a n/a 2.27M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
65.17M 100.14M 138.39M 177.73M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
3.02M 2.74M 2.72M 2.67M
Shares Outstanding (Diluted)
3.02M 2.74M 2.72M 2.67M
EPS (Basic)
-21.44 -37.29 -50.02 -69.51
EPS (Diluted)
-21.44 -37.29 -50.02 -69.51
EBITDA
-61.69M -98.34M -132.45M -183.84M
EBIT
-64.77M -102.06M -136.13M -185.39M
Depreciation & Amortization
3.08M 3.72M 3.68M 1.54M